Skip to main content
. 2022 Jun 15;22:86. doi: 10.1186/s12894-022-01036-1

Table 3.

Practice characteristics

Question Items N %
Practice characteristics
Considering the local where you practice most often
Do patients have easy access to MRI? No 65 15.7
Multiparametric MRI 1.5 Tesla 169 40.9
Multiparametric MRI 3.0 Tesla 141 34.2
Pelvic (unspecified) 38 9.2
The prostate biopsy It is performed at my service, by a urologist 81 19.6
It is performed at my service, by a radiologist 147 35.6
I do it myself 72 17.4
It is outsourced 113 27.4
What is the access of prostate biopsy? Transrectal 410 99.3
Perineal 3 0.7
Number of cores retrieved Sextant (6 cores) 4 1.0
Sextant biopsies (12 cores with 2 of each area) 172 41.6
12 distinct cores of the peripheral zone 57 13.8
12 distinct cores of the peripheral zone plus 2–4 cores of the transition zone 26 7.3
12 distinct cores of the peripheral zone plus 2–4 cores of the transition zone plus additional cores of suspected area (nodule in US or MRI) 142 34.4
Other 12 2.9
Do you have access to biopsy with image fusion? No 197 47.7
Yes, with real-time software fusion 98 23.7
Yes, with cognitive fusion 118 28.6
How long do patients have to wait for a biopsy to be performed? Less than one month 277 67.1
1 to 3 months 119 28.8
3 to 6 months 15 3.6
More than 6 months 2 0.5
Does the histopathological report of the prostate biopsy product provide the Gleason score? Yes, of each fragment alone 363 87.9
Yes, but a general Gleason Score 27 6.5
Yes, for right lobe fragments and another one for left lobe fragments 23 5.6
Does the histopathological report of the prostate biopsy product specify how many fragments are positive? No 7 1.7
Yes 406 98.3
Does the histopathological report of the prostate biopsy product specify the percentage of tumor involvement in each fragment? No 15 3.6
Yes 398 96.4

MRI magnetic resonance imaging, US ultrasound